Products

Quin

Uses AI

Rx savings, telehealth treatments & AI health tracking in one place

quintech.io Health & Wellness / Symptom Checkers & Medical AI

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$9.99/mo
Lower than 58% of peersNiche median $13/mo
Creators
Barry Rogers
No social account linkedCo-created with NowPatient
Launched
6y ago
2020-08-19 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Change the way you think about diabetes

    Aug 19, 2020 · 6y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2018-10-22

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Core
Free
Included · 26 services
Core+
$9.99/mo

Trial: None · Free tier included · 1 paid tier ($9.99) · Observed 2026-11-14 · Source page

Entry price $9.99/mo, Lower than 58% of peers; “Symptom Checkers & Medical AI” median is $13/mo.View pricing benchmark

Website snapshots

Indexed 2020-08-19

Key pages

Desktop & mobile archive
nowpatient.com/ Snapshot 2026-11-14

Questions & evidence

How much does Quin cost?
Core: Free; Core+: $9.99/mo. Observed 2026-11-14. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Quin get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Quin and what platforms does it support?
Quin is catalogued under Symptom Checkers & Medical AI: Rx savings, telehealth treatments & AI health tracking in one place. Supported platforms: Mobile App.

Related products in this category

Health & Wellness / Symptom Checkers & Medical AI

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.